Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.04
-0.17 (-1.20%)
At close: Apr 28, 2026, 4:00 PM EDT
14.04
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Adaptive Biotechnologies Revenue

In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth. Adaptive Biotechnologies had revenue of $71.68M in the quarter ending December 31, 2025, with 51.04% growth.

Revenue (ttm)
$276.98M
Revenue Growth
+54.77%
P/S Ratio
7.81
Revenue / Employee
$443,872
Employees
624
Market Cap
2.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025276.98M98.02M54.77%
Dec 31, 2024178.96M8.68M5.10%
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sarepta Therapeutics 2.20B
Aurinia Pharmaceuticals 283.06M
Zymeworks 105.97M
Ascentage Pharma Group International 82.08M
Mesoblast 65.38M
Ocular Therapeutix 51.95M
Capricor Therapeutics 11.13M
Revenue Rankings

ADPT News

More News